Axicabtagene ciloleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median

Detalles Bibliográficos
Autores principales: Messori, Andrea, Chiumente, Marco, Mengato, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271675/
https://www.ncbi.nlm.nih.gov/pubmed/32547648
http://dx.doi.org/10.1177/1758835920930643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271675/
https://www.ncbi.nlm.nih.gov/pubmed/32547648
http://dx.doi.org/10.1177/1758835920930643

Ejemplares similares